• LifeArc provides £5m funding for COVID-19 genomics study pharmatimes
    February 19, 2021
    LifeArc, a medical research charity, has announced it will provide £5m in funding to support the GenOMICC COVID-19 study, which is aiming to understand the role of genetic risk factors in patient responses to COVID-19.
PharmaSources Customer Service